Small Pharma Reports Fiscal Third Quarter 2023 Highlights
Positive top-line results from Phase IIa trial of SPL026 in Major Depressive Disorder New SPL026 trials underway and screening commenced in the first...
Source: globenewswire.com
Stay updated with breaking news from Duration Psychedelic Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Positive top-line results from Phase IIa trial of SPL026 in Major Depressive Disorder New SPL026 trials underway and screening commenced in the first...